Amol Akhade: How to manage rare endocrine and Neuroendocrine Tumors
Amol Akhade shared a post on LinkedIn:
“How to manage rare endocrine and Neuroendocrine Tumors.
1 – intrathyroid Thymic Carcinoma
2 – Parathyroid carcinoma
3 – metastatic Unknown primary, GuGy Or HN NEN
4 – local or Locoregional head and neck NEN rare tumors
Very useful for clinical practice. Taken from ESMO – European Society for Medical Oncology guidelines.”
Source: Amol Akhade/LinkedIn
Dr. Amol Akhade is a senior consultant medical oncologist and hemato-oncologist. He has received his super specialization training in hemato-oncology and medical oncology from Tata Memorial Hospital.
He specialises in chemotherapy for hematological cancers as well as solid tumors. He also specialises in allogenic and autologous bone marrow transplant. Currently, he is a Consultant Medical Oncologist at Suyog Cancer Clinics and Reliance Hospitals.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023